1. Frigeni, Marta, Balakrishnan, Bijina, Yin, Xue, Pasquali, Marzia, Longo, Nicola. 2017. Functional and molecular studies in primary carnitine deficiency. In Human mutation, 38, 1684-1699. doi:10.1002/humu.23315. https://pubmed.ncbi.nlm.nih.gov/28841266/
2. Mutlu-Albayrak, Hatice, Bene, Judit, Oflaz, Mehmet Burhan, Çaksen, Hüseyin, Melegh, Bela. 2015. Identification of SLC22A5 Gene Mutation in a Family with Carnitine Uptake Defect. In Case reports in genetics, 2015, 259627. doi:10.1155/2015/259627. https://pubmed.ncbi.nlm.nih.gov/26075114/
3. Dinarvand, Negar, Karimi, Farzaneh, Azizi, Reza, Sheikhi, Abdolkarim, Pourfarzam, Morteza. 2022. Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics. In Molecular biology reports, 50, 2061-2066. doi:10.1007/s11033-022-08152-z. https://pubmed.ncbi.nlm.nih.gov/36539562/
4. Loos, Malte, Klampe, Birgit, Schulze, Thomas, Eschenhagen, Thomas, Hansen, Arne. 2023. Human model of primary carnitine deficiency cardiomyopathy reveals ferroptosis as a novel mechanism. In Stem cell reports, 18, 2123-2137. doi:10.1016/j.stemcr.2023.09.002. https://pubmed.ncbi.nlm.nih.gov/37802072/